The Role of Translation Control in Tumorigenesis and Its Therapeutic Implications
Open accessThe DOI matches its Crossref record; 139 of the 139 references it cites were found in a registry or an index.
Abstract
As a convergent mechanism downstream of most oncogenic signals, control of mRNA translation has emerged as a key driver in establishing and tuning gene expression at specific steps in cancer development. Translation control is the most energetically expensive molecular process in the cell that needs to be modulated upon adaption to limited cellular resources, such as cellular stress. It thereby serves as the Achilles’ heel for cancer cells, particularly in response to changes in the microenvironment as well as to nutrient and metabolic shifts characteristic of cancer cell growth and metastasis. In this review, we discuss emerging discoveries that reveal how cancer cells modulate the translation machinery to adapt to oncogenic stress, the mechanisms that guide mRNA translation specificity in cancer, and how this selective mode of gene regulation provides advantages for cancer progression. We also provide an overview of promising preclinical and clinical efforts aimed at targeting the unique vulnerabilities of cancer cells that rely on the remodeling of mRNA translation for their infinite growth and survival.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The RNA helicase eIF4A unwinds the complex 5′ UTR structures of cap-dependent transcripts and is a critical component of the eIF4F translational complex (10, 17).”
From Cotargeting a MYC/eIF4A-survival axis improves the efficacy of KRAS inhibitors in lung cancer (2023) · cites this paper as [10]
Citations
Cites
mTOR: from growth signal integration to cancer, diabetes and ageing
Zoncu, R., Efeyan, A., & Sabatini, D. M. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3025 · Cited by 3,941 · cited 1×
“…of the tuberous sclerosis tumor-suppressor TSC1/2 complex, which is a negative regulator of the mammalian target of rapamycin complex 1 (mTORC1) (Zoncu et al. 2011). mTORC1 activation subsequently induces the phosphorylation of the RP S6 kinase 1/2 (S6K1/2) and 4E-BPs, promoting translation…”
BackgroundAMPK Phosphorylation of Raptor Mediates a Metabolic Checkpoint
Gwinn, D. M., Shackelford, D. B., Egan, D. F., Mihaylova, M. M., Mery, A., Vasquez, D. S., Turk, B. E., & Shaw, R. J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.03.003 · Cited by 3,849
N6-methyladenosine Modulates Messenger RNA Translation Efficiency
Wang, X., Zhao, B. S., Roundtree, I. A., Lu, Z., Han, D., Ma, H., Weng, X., Chen, K., Shi, H., & He, C. (2015) · Cell · doi:10.1016/j.cell.2015.05.014 · Cited by 3,483 · cited 1×
“S ee c op yr ig ht f or a pp ro ve d us e. methyltransferases METTL3 andMETTL14, known as writers; recognized by a cluster of RBPs, known as readers [e.g., YTH family proteins (Wang et al. 2015)]; and erased by demethylases, including FTO and ALKBH5.”
BackgroundeIF4 Initiation Factors: Effectors of mRNA Recruitment to Ribosomes and Regulators of Translation
Gingras, A.-C., Raught, B., & Sonenberg, N. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.913 · Cited by 2,121
PI3K and cancer: lessons, challenges and opportunities
Fruman, D. A., & Rommel, C. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4204 · Cited by 1,709
The m(6)A Methyltransferase METTL3 Promotes Translation in Human Cancer Cells
Lin, S., Choe, J., Du, P., Triboulet, R., & Gregory, R. I. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.03.021 · Cited by 1,531
Eukaryotic Stress Granules: The Ins and Outs of Translation
Buchan, J. R., & Parker, R. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.11.020 · Cited by 1,492
A unifying model for mTORC1-mediated regulation of mRNA translation
Thoreen, C. C., Chantranupong, L., Keys, H. R., Wang, T., Gray, N. S., & Sabatini, D. M. (2012) · Nature · doi:10.1038/nature11083 · Cited by 1,477
Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma
Parsa, A. T., Waldron, J. S., Panner, A., Crane, C. A., Parney, I. F., Barry, J. J., Cachola, K. E., Murray, J. C., Tihan, T., Jensen, M. C., et al. (2007) · Nature Medicine · doi:10.1038/nm1517 · Cited by 1,344
The translational landscape of mTOR signalling steers cancer initiation and metastasis
Hsieh, A. C., Liu, Y., Edlind, M. P., Ingolia, N. T., Janes, M. R., Sher, A., Shi, E. Y., Stumpf, C. R., Christensen, C., Bonham, M. J., et al. (2012) · Nature · doi:10.1038/nature10912 · Cited by 1,313 · cited 3×
“Using genome-wide ribosome profiling experiments in prostate cancer cells treated with mTORATP active site inhibitors, researchers have also identified so-called TOP-like sequences such as the pyrimidine-rich translational element (PRTE) in proinvasive transcripts, including Y box–binding protein 1 (YBX1) and metastas…”
BackgroundSelf-citation
Research works printed but not linked: 3
- Bordeleau ME, 2008, J. Clin. Investig., 118, 2651
- Marchetti A, 2001, Int. J. Oncol., 18, 175
- Nakamura J, 2009, Int. J. Oncol., 34, 1181
Cited by
The plasticity of mRNA translation during cancer progression and therapy resistance
Fabbri, L., Chakraborty, A., Robert, C., & Vagner, S. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-021-00380-y · Cited by 276
Most non-canonical proteins uniquely populate the proteome or immunopeptidome
Ruiz Cuevas, M. V., Hardy, M.-P., Hollý, J., Bonneil, É., Durette, C., Courcelles, M., Lanoix, J., Côté, C., Staudt, L. M., Lemieux, S., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108815 · Cited by 203
Translational control of stem cell function
Saba, J. A., Liakath-Ali, K., Green, R., & Watt, F. M. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00386-2 · Cited by 194
ERα is an RNA-binding protein sustaining tumor cell survival and drug resistance
Xu, Y., Huangyang, P., Wang, Y., Xue, L., Devericks, E., Nguyen, H. G., Yu, X., Oses-Prieto, J. A., Burlingame, A. L., Miglani, S., et al. (2021) · Cell · doi:10.1016/j.cell.2021.08.036 · Cited by 165
Self-citationProtein synthesis control in cancer: selectivity and therapeutic targeting
Kovalski, J. R., Kuzuoğlu‐Öztürk, D., & Ruggero, D. (2022) · The EMBO Journal · doi:10.15252/embj.2021109823 · Cited by 132
Self-citation
Metadata
- Authors
- Xu, Y., & Ruggero, D.
- Affiliations
- University of California, San Francisco (US)
- Venue
- Annual Review of Cancer Biology
- Publisher
- Annual Reviews
- Published
- 2020-03-09
- Volume
- 4
- Issue
- 1
- Pages
- 437-457
- ISSN
- 2472-3428 (ISSN-L)
- OpenAlex
- W2994162014
- Cited by
- 67
- References
- 137
- Citations by year
- 2026: 8 · 2025: 11 · 2024: 13 · 2023: 17 · 2022: 10 · 2021: 7 · 2020: 1
- FWCI
- 0.40
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Annual Review of Cancer Biology (publishedVersion, cc-by)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Keywords
- translational regulation, carcinogenesis, mRNA translation, oncogenic stress, cancer metabolism, tumor microenvironment, tumor progression, metastasis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Role of Translation Control in Tumorigenesis and Its Therapeutic Implications. https://app.cochat.ai/papers/10.1146/annurev-cancerbio-030419-033420
- The paper
- Xu, Y., & Ruggero, D. (2020). The Role of Translation Control in Tumorigenesis and Its Therapeutic Implications. Annual Review of Cancer Biology. https://doi.org/10.1146/annurev-cancerbio-030419-033420
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.